Resveratrol and First-degree Relatives of Type 2 Diabetic Patients

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

April 30, 2017

Study Completion Date

July 31, 2017

Conditions
Pre-diabetes
Interventions
DIETARY_SUPPLEMENT

placebo

A placebo will given for 30 days or 34 days (if included in brown adipose tissue measurement), twice daily. One pill will be provided with lunch, and the other pill will be provided with dinner.

DIETARY_SUPPLEMENT

resveratrol

resveratrol will be given for 30 days or 34 days (if included in brown adipose tissue measurement), twice daily. One pill, which contains 75 mg of resveratrol, will be provided with lunch, and the other pill, also containing 75 mg will be given with dinner. So in total a dose of 150 mg/day will be given.

Trial Locations (1)

6200 MD

Maastricht University Medical Centre, Maastricht

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

DSM Nutritional Products, Inc.

INDUSTRY

collaborator

Diabetes Fonds

OTHER

lead

Maastricht University Medical Center

OTHER

NCT02129595 - Resveratrol and First-degree Relatives of Type 2 Diabetic Patients | Biotech Hunter | Biotech Hunter